Astins A and B, antitumor cyclic pentapeptides from Aster tataricus

Area of Science:

• Natural Product Chemistry
• Medicinal Chemistry
• Pharmacognosy

Background:

• Aster tataricus is a plant species known for its potential medicinal properties.
• Cyclic peptides are a class of compounds with diverse biological activities, including antitumor effects.
• Identifying novel bioactive compounds from natural sources is crucial for drug discovery.

Purpose of the Study:

• To isolate and characterize novel cyclic pentapeptides from Aster tataricus.
• To elucidate the structures of these newly identified compounds.
• To investigate their potential as antitumor agents.

Main Methods:

• Isolation of compounds using chromatographic techniques.
• Structure elucidation through comprehensive spectroscopic analysis (NMR, MS).
• Chemical degradation studies to confirm structural features.

Main Results:

• Two novel cyclic pentapeptides, astins A and B, were isolated and characterized.
• Both astins A and B were found to be isomers with a cis configuration in one amide bond.
• The structures were confirmed by spectroscopic data and chemical degradation.
• Astins A and B contain chlorine and allo-threonine residues.

Conclusions:

• The study successfully identified and characterized two new antitumor cyclic pentapeptides from Aster tataricus.
• The unique structural features, including isomerism and cis-amide bonds, provide insights into structure-activity relationships.
• These findings contribute to the understanding of Aster tataricus's chemical constituents and their potential therapeutic applications.